You are here

Industry Trends

Cash exchanged for confidential reports and schedules that were used for false claims
Commission compares the drug crisis to the 9/11 attacks
Problem can be particularly dangerous for women
2018 preferred formulary hits Lilly and Amgen but spares diabetes
The suspect in Indiana, a state gripped by addiction problems, took his own life
Violations focused on promotion of Thalomid and Revlimid
U.S. poses challenges for biosimilars, consultant argues
Government, industry, and advocacy groups collaborate on Expanded Access Navigator
Still, some facilities are dipping a toe into the water
The move is an effort to spread the sharing of risk
National Academies report urges a much more systematic approach
Pascal Soriot might leave the company he’s shaken up
The concept: plans pay more for treatments that work
Emotional and religious support may be lacking
Study shows memory improved about 40%
In a positive sign, new VA secretary received unanimous approval
Gallup survey shows uninsured rate up from 10.9% in last half of 2016
Brenda Fitzgerald ran twice for Congress in Georgia
Longer durations, ACO integration, and non-hospital services would aid cost-effectiveness